| 1. |
- Bungart, D, et al.
(författare)
-
Occurrence of analogues of the myotropic neuropeptide orcokinin in the shore crab, Carcinus maenas : evidence for a novel neuropeptide family.
- 1995
-
Ingår i: Peptides. - 0196-9781 .- 1873-5169. ; 16:1, s. 67-72
-
Tidskriftsartikel (refereegranskat)abstract
- By use of an enzyme immunoassay that was developed for the determination of orcokinin, a myotropic neuropeptide of the sequence NFDEIDRSGFGFN from the crayfish, Orconectes limosus, immunoreactive material was detected in extracts of thoracic ganglia from the shore crab, Carcinus maenas. Isolation of the immunoreactive material was achieved by the following steps: 1) prepurification by gel filtration, 2) immunoaffinity chromatography on an anti-orcokinin IgG protein-A sepharose column, and 3) reversed-phase HPLC. The HPLC profile after affinity purification revealed three main immunoreactive peptides that were rechromatographed. None of these peptides was identical to orcokinin in terms of retention time. Automated gas-phase sequencing revealed these peptides to be analogues of orcokinin differing in one amino acid residue. They were named [Ser9]-, [Ala13]- and [Val13]orcokinin (NFDEIDRSSFGFN, Mr 1549.3; NFDEIDRSGFGFA, Mr 1475.3; NFDEIDRSGFGFV, Mr 1503.9). Carboxypeptidase A treatment of the peptides indicated a free C-terminus. Complete characterization of the three peptides was achieved from approximately 230 thoracic ganglia of Carcinus maenas.
|
|
| 2. |
- Bungart, D, et al.
(författare)
-
Quantitative determination and distribution of the myotropic neuropeptide orcokinin in the nervous system of astacidean crustaceans.
- 1994
-
Ingår i: Peptides. - : Elsevier BV. - 0196-9781 .- 1873-5169. ; 15:3, s. 393-400
-
Tidskriftsartikel (refereegranskat)abstract
- For quantitative determinations of orcokinin, an indirect, noncompetitive sandwich ELISA was developed. This ELISA is highly specific for orcokinin and the detection limit is 1 fmol. In three astacidean species (Orconectes limosus, Homarus americanus, and Astacus astacus) orcokinin immunoreactivity (OK-IR) was measurable in all parts of the nervous system. Upon normalization to the protein content of the tissue (pmol/mg protein), concentrations were shown to be in the same range in all three species. The distribution of OK-IR in the nervous system is also very similar in the three species. In Orconectes limosus the following values were obtained (in pmol/mg protein): cerebral ganglion 215, optic ganglia in the eyestalk 38, subesophageal ganglion 182. The thoracic ganglia have lower concentrations (35-72) and the abdominal ganglia (AG) 1-5 even lower ones (11-17). In the AG 6 of Orconectes, from which the innervation of the hindgut arises, concentrations are approximately five times higher than in the other AG. In hindgut tissue, relatively high concentrations of 22 pmol/mg were measured, which is in agreement with the demonstrated function of orcokinin as a hindgut excitatory substance. Markedly elevated levels of orcokinin were observed in the AG 6 of Astacus, but not in Homarus. Orcokinin could also be measured consistently and reliably in the hemolymph, where its concentration is approximately 1 x 10(-11) M. These results show that orcokinin may be released into the hemolymph and may act as a hormone, in addition to its role as a locally acting neurotransmitter/modulator.
|
|
| 3. |
- Dircksen, Heinrich, 1954-, et al.
(författare)
-
Structure, distribution, and biological activity of novel members of the allatostatin family in the crayfish Orconectes limosus.
- 1999
-
Ingår i: Peptides. - 0196-9781 .- 1873-5169. ; 20:6, s. 695-712
-
Tidskriftsartikel (refereegranskat)abstract
- In the central and peripheral nervous system of the crayfish, Orconectes limosus, neuropeptides immunoreactive to an antiserum against allatostatin I (= Dipstatin 7) of the cockroach Diploptera punctata have been detected by immunocytochemistry and a sensitive enzyme immunoassay. Abundant immunoreactivity occurs throughout the central nervous system in distinct interneurons and neurosecretory cells. The latter have terminals in well-known neurohemal organs, such as the sinus gland, the pericardial organs, and the perineural sheath of the ventral nerve cord. Nervous tissue extracts were separated by reverse-phase high-performance liquid chromatography and fractions were monitored in the enzyme immunoassay. Three of several immunopositive fractions have been purified and identified by mass spectroscopy and microsequencing as AGPYAFGL-NH2, SAGPYAFGL-NH2, and PRVYGFGL-NH2. The first peptide is identical to carcinustatin 8 previously identified in the crab Carcinus maenas. The others are novel and are designated orcostatin I and orcostatin II, respectively. All three peptides exert dramatic inhibitory effects on contractions of the crayfish hindgut. Carcinustatin 8 also inhibits induced contractions of the cockroach hindgut. Furthermore, this peptide reduces the cycle frequency of the pyloric rhythms generated by the stomatogastric nervous system of two decapod species in vitro. These crayfish allatostatin-like peptides are the first native crustacean peptides with demonstrated inhibitory actions on hindgut muscles and the pyloric rhythm of the stomatogastric ganglion.
|
|
| 4. |
- Hallberg, Mathias, et al.
(författare)
-
Anabolic-androgenic steroids affect the content of substance P and substance P(1-7) in the rat brain
- 2000
-
Ingår i: Peptides. - 0196-9781 .- 1873-5169. ; 21:6, s. 845-852
-
Tidskriftsartikel (refereegranskat)abstract
- The effects of intramuscular (i.m.) injections of nandrolone decanoate (15 mg/kg/day), an anabolic-androgenic steroid, on the levels of substance P (SP) and on its N-terminal fragment SP(1-7) were examined in the male rat brain by radioimmunoassay. The results demonstrated that the SP immunoreactivity in amygdala, hypothalamus, striatum, and periaqueductal gray was significantly enhanced, whereas the concentration of the N-terminal fragment SP(1-7) was enhanced in the nucleus accumbens and in periaqueductal gray. In the striatum the steroid induced a decrease in the content of SP(1-7). The relevance of these peptides in connection with anabolic-androgenic steroid-induced aggression is discussed.
|
|
| 5. |
- Koskinen, Lars-Owe D., Professor, 1955-
(författare)
-
Cerebral and peripheral blood flow effects of TRH in the rat : a role of vagal nerves
- 1989
-
Ingår i: Peptides. - : Elsevier BV. - 0196-9781 .- 1873-5169. ; 10:5, s. 933-938
-
Tidskriftsartikel (refereegranskat)abstract
- The cardiovascular effects of the IV infusion of TRH were studied in the rat. TRH tended to increase the MAP and markedly increased the CBF(tot) in the control group, in vagotomized animals and in methylatropine-pretreated rats. A marked vasodilation was noted in the pancreas, gastric mucosa, duodenum and cardiac muscle. This effect was turned to vasoconstriction, the heart excluded, in vagotomized animals. Muscarinic blockade attenuated the vasodilating effect of TRH in the duodenum and gastric mucosa. The results indicate that TRH elicits cerebral vasodilation and a partly nonmuscarinic parasympathetically mediated vasodilation in several gastrointestinal organs in parallel with a vasoconstriction which is unmasked by vagotomy.
|
|
| 6. |
- Koskinen, Lars-Owe D., Professor, 1955-
(författare)
-
Naloxone and TRH affect regional blood flows in the anesthetized rabbit.
- 1991
-
Ingår i: Peptides. - : Elsevier BV. - 0196-9781 .- 1873-5169. ; 12:6, s. 1273-1277
-
Tidskriftsartikel (refereegranskat)abstract
- The cardiovascular effects of IV naloxone and a subsequent administration of TRH IV were studied in the rabbit. Naloxone caused a vasodilation in the myocardium and adrenal glands. Naloxone elicited an increment in cerebral blood flow in several regions which attenuated the cerebrovasodilating effect of TRH in a few regions. The blockade of endogenous opioids with naloxone did not modify the peripheral vasoconstricting effect of TRH or affect the vascular effects of TRH mediated by the peripheral sympathetic nerves. The results indicate that naloxone has a vasodilating effect in the myocardium and CNS in anesthetized rabbits. The major part of the cardiovascular effect of TRH is not dependent on mechanisms sensitive to naloxone.
|
|
| 7. |
- Koskinen, Lars-Owe D., Professor, 1955-, et al.
(författare)
-
Nitric oxide inhibition by L-NAME but not 7-NI induces a transient increase in cortical cerebral blood flow and affects the cerebrovasodilation induced by TRH
- 2003
-
Ingår i: Peptides. - : Elsevier. - 0196-9781 .- 1873-5169. ; 24:4, s. 579-583
-
Tidskriftsartikel (refereegranskat)abstract
- The tripeptide thyrotropin releasing hormone (TRH) has multiple interesting and complex physiological effects. One of these is the cerebrovasodilating effect, which has been described under several different conditions. The final mechanism for this effect is unknown. In the present study, we found an initial atropine-resistant cerebral vasodilation (24%) elicited by the NOS inhibitor L-NAME in the rat. D-NAME and 7-NI did not produce this effect. TRH (300 microg kg(-1), i.v.) induced an increase in cerebral blood flow by 62%. L-NAME reduced this effect significantly. The cerebrovasodilating mechanism of TRH, at least in part, is endothelial NO dependent as the neuronal 7-NI NOS inhibitor does not affect the TRH response.
|
|
| 8. |
- Koskinen, Lars-Owe D., Professor, 1955-, et al.
(författare)
-
The neuropeptide TRH has a minor effect on the enzymatic activity of acetylcholinesterase in vitro.
- 1998
-
Ingår i: Peptides. - : Elsevier BV. - 0196-9781 .- 1873-5169. ; 19:10, s. 1675-1677
-
Tidskriftsartikel (refereegranskat)abstract
- The neuropeptide thyrotropin-releasing hormone (TRH) elicits a variety of physiological effects of which some are due to cholinergic mechanisms. TRH modulates in vivo the effects of compounds affecting acetylcholinesterase (AChE). In the present study the in vitro effects of TRH on the activity of AChE were explored. TRH has no effect at physiologically relevant concentrations. At unphysiologically high concentrations (>5 mM) a slight inhibition was found. This was noticed also when the enzyme was exposed to the amide-free tripeptide analog p-Glu-His-Pro. We conclude that any cholinergic effect of TRH observed in vivo is unlikely to be due to a direct interaction of the peptide with AChE.
|
|
| 9. |
- Larsson, Jan, et al.
(författare)
-
Effects of TRH and atropine on induction and duration of anesthesia with propofol in rats.
- 1996
-
Ingår i: Peptides. - : Elsevier BV. - 0196-9781 .- 1873-5169. ; 17:2, s. 293-297
-
Tidskriftsartikel (refereegranskat)abstract
- The effects of IV TRH pretreatment on induction of anesthesia with propofol or pentobarbital were investigated in rats. The effects of IV TRH, administered after induction, on duration of propofol anesthesia and the interaction with atropine were also studied. The doses of propofol or pentobarbital were not influenced by TRH. TRH reduced duration of anesthesia after propofol, with higher brain concentrations of propofol at recovery. Atropine did not block this effect, but given alone prolonged duration of anesthesia. It is concluded that TRH shortens the duration of propofol anesthesia, probably due to a pharmacodynamic effect and not to a pharmacokinetic interaction.
|
|
| 10. |
- Magnusson, B. M., et al.
(författare)
-
Biological effects after percutaneous absorption of thyrotropin-releasing hormone and its analogue M-TRH
- 2001
-
Ingår i: Peptides. - : Elsevier. - 0196-9781 .- 1873-5169. ; 22:1, s. 73-79
-
Tidskriftsartikel (refereegranskat)abstract
- Besides its well known endocrinological effects, thyrotropin-releasing hormone (TRH) has potential clinical value in the treatment of neurotrauma and various neurologic and psychiatric disorders. The aim of this study was to assess if transdermal delivery of TRH and its analogue, M-TRH, in the presence of enhancers, is an effective means for administration of the peptides. Using the in vitro diffusion cell method, the effect of ethanol and a terpene on the transdermal penetration of the peptides across full-thickness rat skin were studied. Steady-state permeability values for TRH and M-TRH were 8.7 +/- 2.2 and 6.7 +/- 1.4 microg/cm(2) h, respectively. The addition of 3 % terpene in combination with 47 % ethanol increased the penetration of TRH and M-TRH to 16.2 +/- 1.7 and 14.6 +/- 2.1 microg/cm(2) h, respectively. Rats were studied in vivo for release of thyroid-stimulating hormone (TSH) as a biologic effect after transdermally delivered peptide. Topical application of TRH and M-TRH induced an increase in TSH serum concentration from 0.32 +/- 0.09 ng/ml to 32.6 +/- 5.0 and 22.9 +/- 7.6 ng/ml, respectively, after 30 min. The addition of terpene and ethanol in combination with TRH or M-TRH, increased the TSH release to 43.0 +/- 3.8 and 48.4 +/- 4.0 ng/ml, respectively. It is concluded that, in the rat, peptides can be absorbed through the skin with retained biologic activity, and in amounts sufficient to elicit a physiological response.
|
|
